Bio-Rad Laboratories down after Q4 sales miss

Bio-Rad Laboratories

14/02/2025 18:01

** Shares of California-based diagnostic firm Bio-Rad
 BIO.N  down 8.25% at $281.10 
    ** Co reports Q4 sales of $667.5 million, missing analysts'
estimate of $679.3 million, according to data compiled by LSEG
    ** Expects 2025 revenue growth of about 1.5% to 3.5% and
operating margin of ~13% to 13.5% 
    ** The forecast is mixed, as core growth bracketed
expectations, but margins disappointed - Jefferies
    ** Co says will lay off about 5% of its workforce as a part
of its restructuring plan - filing
    ** Adds will incur between about $45 million and $50 million
in costs
    ** It reported Q4. adj profit of $2.9 vs est. $2.87
    ** In the last 12 months, the stock has fallen ~15%

 (Reporting by Siddhi Mahatole)
 ((Siddhiprabhanjan.mahatole@thomsonreuters.com))